Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Bragadiru – page 25

671 clinical trials in Bragadiru, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Bragadiru at a glance
671
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

671 trials in Bragadiru

Open in trial search

Osteoarthritis

Not yet recruiting

Study on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:HIS203-CRM197
  • Sponsor:Peptinov

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Avacopan
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited

Cardiac failure acute+1

Not yet recruiting

Efficacy of istaroxime versus placebo (sodium chloride) infusion in patients with cardiogenic shock due to acute heart failure

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Istaroxime
  • Sponsor:Seismic Pharmaceuticals Operations LLC

Colitis ulcerative

Not yet recruiting

Evaluation of the Efficacy and Safety of Ponesimod in Patients with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ponesimod
  • Sponsor:Vanda Pharmaceuticals Inc.

Breast cancer+2

Not yet recruiting

Gedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Celcuity Inc.

Adenocarcinoma gastric+1

Not yet recruiting

A Phase 3 Study of ASP2138 Plus Drug Combination in Adults with HER2‑Negative, CLDN18.2‑Positive Advanced Gastric Cancer (First‑Line Treatment)

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Astellas Pharma Global Development Inc.

Schizophrenia

Not yet recruiting

Phase 3 Double‑Blind Relapse Prevention Trial of Trospium Chloride and Xanomeline Tartrate (KarXT) in Adults with Schizophrenia

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Anaemia+1

Not yet recruiting

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Breast cancer+2

Not yet recruiting

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Laboratorios Farmaceuticos Rovi S.A.

Type 2 diabetes mellitus

Not yet recruiting

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Albiglutide
  • Sponsor:Eli Lilly & Co.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Bragadiru

What the registry says about research in the country

01 Respiratory Disease Management

Innovative research focusing on moderate to severe asthma treatments, evaluating new inhaler formulations and their safety profiles. Studies aim to improve bronchodilation and reduce exacerbations in patients following GINA guidelines.

  • Asthma Control Studies
  • Inhaler Technology Assessment
  • Bronchodilation Research

Multiple trials examining maintenance therapy optimization for better patient outcomes.

02 COPD Research Initiatives

Comprehensive studies exploring chronic obstructive pulmonary disease treatments, including evaluation of triple combination therapies and novel biological agents for moderate to severe cases.

  • Lung Function Enhancement
  • Exacerbation Prevention
  • Long-term Safety Studies

Focus on improving quality of life for patients with chronic respiratory conditions.

03 Advanced Therapeutic Solutions

Investigation of targeted treatments for severe eosinophilic asthma and development of innovative rescue medications. Research includes long-term efficacy studies of biological treatments.

  • Biological Therapy Evaluation
  • Rescue Medication Development
  • Extended Duration Trials

Emphasis on personalized treatment approaches for specific patient populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.